Celyad SA/NV (NASDAQ: CYAD), a leader in the discovery and development of CAR-T cell therapies, today announced the initiation of ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE